tomeko

Keratoderma with scleroatrophy of the extremities

Just diagnosed with Keratoderma with scleroatrophy of the extremities?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Keratoderma with scleroatrophy of the extremities, look for clinical trials, and connect with others living with it — all in one place.

Open the full Keratoderma with scleroatrophy of the extremities hub →

Overview

Keratoderma with scleroatrophy of the extremities is a rare condition. Also known as Palmoplantar hyperkeratosis-sclerodactyly syndrome, Palmoplantar keratoderma-sclerodactyly syndrome, Scleroatrophic syndrome, Sclerotylosis. Tomeko brings together the specialists, research, clinical trials, treatments and community for Keratoderma with scleroatrophy of the extremities so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:384 · OMIM 181600 · ICD-10 Q82.8 · GARD 0008517

Find care for Keratoderma with scleroatrophy of the extremities

Authoritative references for Keratoderma with scleroatrophy of the extremities

Common questions

I was just diagnosed with Keratoderma with scleroatrophy of the extremities — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Keratoderma with scleroatrophy of the extremities, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Keratoderma with scleroatrophy of the extremities?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Keratoderma with scleroatrophy of the extremities, filtered to your area.

Are there clinical trials for Keratoderma with scleroatrophy of the extremities?

Tomeko shows live, recruiting studies for Keratoderma with scleroatrophy of the extremities from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com